Helicon Group Limited (ASX:HCG) Appoints Aleksandra Gajda To Stakeholder Relations Manager

Perth, Jan 24, 2008 (ABN Newswire) - HELICON GROUP LIMITED (ASX: HCG) today announced the appointment of Aleksandra Gajda to the position of Stakeholder Relations Manager.

Ms Gajda holds a Mass Communication (B.A) degree from Curtin University of Technology majoring in Public Relations, Marketing and Journalism.

Her key role will be to ensure that the company's stakeholders are kept up to date with ongoing developments as it implements its ambitious growth plans.

Helicon is approaching first regulatory approvals in China, negotiating the in licensing of new technologies and reviewing tactical alliance opportunities.

Ms Gajda's appointment is part of a strategic initiative that recognises Helicon's need to keep stakeholders aware of its advancements.

She said the opportunity to work at Helicon would enable her to contribute to the company's development as it enters a period of swift change.

"I am very excited to be part of such a new and rapidly expanding company; there are many plans in the pipeline for Helicon and I welcome the challenge of being involved in this growth opportunity," said Ms Gajda.

"This is a key strategic appointment enabling us to keep our stakeholders apprised of the ongoing development of our business. I am thrilled that we have managed to attract a stakeholder relations professional of the calibre of Aleksandra and warmly welcome her to Helicon, "commented Peter Abrahamson, Helicon's CEO.

Ms Gajda took up her position with Helicon Group in January 2008.

About Helicon Group Limited

Helicon is listed on the Australian Securities Exchange. The Company's business is to identify and exploit niche market opportunities in the biomedical markets of North Asia, specifically China and to participate in the significant growth that has been projected for these markets over the next 25 years.

Helicon looks for "Special Situations" for advanced Western biopharmaceutical products that are not available in China or other North Asian Markets or where there are market needs that are not being adequately provided for.

Helicon's product partners are likely to be innovative small to medium sized pharmaceutical and healthcare enterprises focused largely on western markets.

Helicon seeks exclusive licenses for the designated markets and utilises a low cost operating overhead base in combination with established channel partners for product registration, distribution, marketing, and sales.